Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
20 studies found for:    Open Studies | "Rickets"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Rickets" (20 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting Iron Therapy for Autosomal Dominant Hypophosphatemic Rickets: A Pilot Project.
Condition: Autosomal Dominant Hypophosphatemic Rickets
Intervention: Dietary Supplement: Iron
2 Unknown  Effect of Cinacalcet on Parathyroid Hormone Secretion in Children and Adolescents With Hypophosphatemic Rickets
Condition: Hypophosphatemic Rickets, X-Linked Dominant
Intervention: Drug: Cinacalcet
3 Recruiting A Study of KRN23 in Subjects With X-linked Hypophosphatemic Rickets/Osteomalacia
Condition: X-linked Hypophosphatemic Rickets/Osteomalacia
Intervention: Drug: KRN23
4 Recruiting Calcitonin for Treating X-linked Hypophosphatemia
Condition: Hypophosphatemic Rickets, X Linked Dominant
Interventions: Drug: nasal salmon calcitonin;   Drug: Saline Nasal Spray Placebo
5 Unknown  Pilot Study: Hypovitaminosis D, Hyperparathyroidism and Hypomagnesemia in Patients With Congestive Heart Failure
Conditions: Congestive Heart Failure;   Hypovitaminosis D;   Hypomagnesemia;   Hyperparathyroidism
Intervention:
6 Recruiting Resistance to Vitamin D or Parathyroid Hormone
Conditions: Hypocalcemia;   Pseudohypoparathyroidism;   Albright Hereditary Osteodystrophy;   Rickets
Intervention:
7 Not yet recruiting Vitamin D, Iodine, and Lead Levels in Haitian Infants and Children.
Conditions: Vitamin D Deficiency;   Iodine Deficiency;   Hypothyroidism;   Rickets;   Lead Intoxication
Intervention:
8 Not yet recruiting Long-Term Extension Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia (XLH)
Condition: X-Linked Hypophosphatemia
Intervention: Drug: KRN23
9 Recruiting Cinacalcet for Fibroblast Growth Factor 23 (FGF23)-Mediated Hypophosphatemia (Hypophosphatemic Rickets)
Condition: Osteomalacia
Intervention: Drug: Osteomalacia
10 Not yet recruiting Vitamin D Status in Lower Extremity Joint Replacement Surgery Patients
Condition: Hypovitaminosis D
Interventions: Dietary Supplement: Cholecalciferol;   Dietary Supplement: Placebo
11 Unknown  Diabetes Intervention Trial With Vitamin D in Subjects of Nordic and Sub-Indian Ethnicity
Conditions: Diabetes Mellitus Type 2;   Hypovitaminosis D
Interventions: Drug: Cholecalciferol;   Other: Orange juice
12 Unknown  Serum Sclerostin Levels, Cardiovascular Parameters and Carpal Tunnel Syndrome in Maintenance Hemodialysis Patients
Conditions: Chronic Kidney Disease;   Renal Osteodystrophy;   Left Ventricular Hypertrophy
Intervention:
13 Recruiting Molecular Pathways Involved in the Pathogenesis and Behavior of Mesenchymal Phosphaturic Tumors Causing Oncogenic Osteomalacia
Condition: Tumor Induced Oncogenic Osteomalacia
Intervention:
14 Unknown  Kidney Yin/Yang Replenishment on Patients With Renal Osteodystrophy
Conditions: Renal Insufficiency, Chronic;   Renal Osteodystrophy
Interventions: Drug: Yougui granules;   Drug: Zuogui granules;   Drug: Yougui granules placebo;   Drug: Zuogui granules placebo
15 Not yet recruiting Study of KRN23 in Adult Subjects With Tumor-Induced Osteomalacia (TIO) or Epidermal Nevus Syndrome (ENS)
Conditions: Tumor Induced Osteomalacia (TIO);   Epidermal Nevus Syndrome (ENS)
Intervention: Drug: KRN23
16 Recruiting Clinical Observation on Bone Metabolism Induced by Chronic Renal Insufficiency
Conditions: Chronic Renal Insufficiency;   Renal Osteodystrophy
Intervention:
17 Recruiting Renal Osteodystrophy: A Fresh Approach
Condition: Renal Osteodystrophy
Intervention:
18 Recruiting 68Ga-DOTATATE PET/CT in Oncogenic Osteomalacia
Conditions: Oncogenic Osteomalacia;   Mesenchymal Tumor
Intervention: Drug: 68Ga-DOTATATE
19 Recruiting Open-Label Study of Asfotase Alfa in Infants and Children ≤ 5 Years of Age With Hypophosphatasia (HPP)
Condition: Hypophosphatasia
Intervention: Drug: asfotase alfa
20 Recruiting Effects of Vitamin D3 Versus 25OHD3 on Mineral Metabolism and Immune Function
Condition: Vitamin D Deficiency
Interventions: Drug: Vitamin D;   Drug: 25(OH)D3

Indicates status has not been verified in more than two years